This systematic review aimed to evaluate the presence and number of CD34+ cells in individuals with Alzheimer’s disease (AD) to better understand the role of vascular factors in the pathogenesis of neurodegenerative conditions (Figure 4). This evidence concerns the gene CD34 and Alzheimer disease.